Brigitte Cheuvart

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 14

Top Topics

Chronic Obstructive Pulmonary Disease

Immune Response

Top Venues

Human vaccines & immunotherapeutics

Expert review of vaccines

This page only lists publications with an associated author ORCID identifier.

Publications

Federico M Torres, Ignacio Salamanca de la Cueva, Michael Horn, Soeren Westerholt, Samantha Bosis, Nadia Meyer, Brigitte Cheuvart, Navpreet Virk, Rupert W Jakes, Maurine Duchenne, Peter Van den Steen
Disparate kinetics in immune response of two different Haemophilus influenzae type b conjugate vaccines: Immunogenicity and safety observations from a randomized controlled phase IV study in healthy infants and toddlers using a 2+1 schedule. Human vaccines & immunotherapeutics 20 (1) (2024)
Federico M Torres, Ignacio Salamanca de la Cueva, Michael Horn, Soeren Westerholt, Samantha Bosis, Nadia Meyer, Brigitte Cheuvart, Navpreet Virk, Rupert W Jakes, Maurine Duchenne, Peter Van den Steen
Disparate kinetics in immune response of two different Haemophilus influenzae type b conjugate vaccines: Immunogenicity and safety observations from a randomized controlled phase IV study in healthy infants and toddlers using a 2+1 schedule. Human vaccines & immunotherapeutics 20 (1) (2024)
Federico M Torres, Ignacio Salamanca de la Cueva, Michael Horn, Soeren Westerholt, Samantha Bosis, Nadia Meyer, Brigitte Cheuvart, Navpreet Virk, Rupert W Jakes, Maurine Duchenne, Peter Van den Steen
Disparate kinetics in immune response of two different Haemophilus influenzae type b conjugate vaccines: Immunogenicity and safety observations from a randomized controlled phase IV study in healthy infants and toddlers using a 2+1 schedule. Human vaccines & immunotherapeutics 20 (1) (2024)
Federico M Torres, Ignacio Salamanca de la Cueva, Michael Horn, Soeren Westerholt, Samantha Bosis, Nadia Meyer, Brigitte Cheuvart, Navpreet Virk, Rupert W Jakes, Maurine Duchenne, Peter Van den Steen
Disparate kinetics in immune response of two different Haemophilus influenzae type b conjugate vaccines: Immunogenicity and safety observations from a randomized controlled phase IV study in healthy infants and toddlers using a 2+1 schedule. Human vaccines & immunotherapeutics 20 (1) (2024)
Peter Van den Steen, Brigitte Cheuvart, Quentin Deraedt, Laura Valdes Verelst, Daria Shamarina
Immunogenicity and safety of reduced-antigen tetanus, diphtheria and acellular pertussis vaccination in adults treated for obstructive airway diseases. Human vaccines & immunotherapeutics 19 (1) (2023)
Peter Van den Steen, Brigitte Cheuvart, Quentin Deraedt, Laura Valdes Verelst, Daria Shamarina
Immunogenicity and safety of reduced-antigen tetanus, diphtheria and acellular pertussis vaccination in adults treated for obstructive airway diseases. Human vaccines & immunotherapeutics 19 (1) (2023)
Peter Van den Steen, Brigitte Cheuvart, Quentin Deraedt, Laura Valdes Verelst, Daria Shamarina
Immunogenicity and safety of reduced-antigen tetanus, diphtheria and acellular pertussis vaccination in adults treated for obstructive airway diseases. Human vaccines & immunotherapeutics 19 (1) (2023)
Peter Van den Steen, Brigitte Cheuvart, Quentin Deraedt, Laura Valdes Verelst, Daria Shamarina
Immunogenicity and safety of reduced-antigen tetanus, diphtheria and acellular pertussis vaccination in adults treated for obstructive airway diseases. Human vaccines & immunotherapeutics 19 (1) (2023)
Peter Van den Steen, Brigitte Cheuvart, Quentin Deraedt, Laura Valdes Verelst, Daria Shamarina
Immunogenicity and safety of reduced-antigen tetanus, diphtheria and acellular pertussis vaccination in adults treated for obstructive airway diseases. Human vaccines & immunotherapeutics 19 (1) (2023)
Peter Van den Steen, Brigitte Cheuvart, Quentin Deraedt, Laura Valdes Verelst, Daria Shamarina
Immunogenicity and safety of reduced-antigen tetanus, diphtheria and acellular pertussis vaccination in adults treated for obstructive airway diseases. Human vaccines & immunotherapeutics (2023)
Peter Van den Steen, Brigitte Cheuvart, Quentin Deraedt, Laura Valdes Verelst, Daria Shamarina
Immunogenicity and safety of reduced-antigen tetanus, diphtheria and acellular pertussis vaccination in adults treated for obstructive airway diseases. Human vaccines & immunotherapeutics 19 (1) (2023)
Brigitte Cheuvart, Bart Spiessens, Roy van Heesbeen, Derchieh Hung, Coralie Andrade, Joanna Korejwo-Peyramond, Fernanda Tavares-Da-Silva
Harmonizing the collection of solicited adverse events in prophylactic vaccine clinical trials. Expert review of vaccines (2023)
Thomas M A Wilkinson, Peter Van den Steen, Brigitte Cheuvart, Nathalie Baudson, Monique Dodet, Elisa Turriani, Lauriane Harrington, Nadia Meyer, Simona Rondini, Laura Taddei, Piyali Mukherjee
Seroprevalence of Bordetella pertussis Infection in Patients With Chronic Obstructive Pulmonary Disease in England: Analysis of the AERIS Cohort. COPD 18 (3) (2021)
Catherine Cohet, Brigitte Cheuvart, Leentje Moerman, Dan Bi, Adrian Caplanusi, Mallesh Kariyappa, Sanjay Lalwani, Monjori Mitra, Amita Sapru, Shruti Saha, P V Varughese, Rajeev Zachariah Kompithra, Sanjay Gandhi
A phase III randomized, open-label, non-inferiority clinical trial comparing liquid and lyophilized formulations of oral live attenuated human rotavirus vaccine (HRV) in Indian infants. Human vaccines & immunotherapeutics (2021)